Extended release nicotinic acid - A novel oral agent for phosphate control

International Urology and Nephrology

Volumn 38, Issue 1, 2006, Pages 171-174

  Sampathkumar, Krishnaswamy ^a,b   Selvam, Manickam ^a   Sooraj, Yesudas Santhakumari ^a   Gowthaman, Sankaran ^a   Ajeshkumar, Rajappan Nair Prabha ^a  

^a Meenakshi Mission Hospital   (India)

^b NONE   (India)

Author keywords

Alkaline phosphatase; Calcium; Hemodialysis; Nicotinic acid; Phosphate binder; Phosphorus; Pruritus; Small intestine; Sodium Phosphate co transporter

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM PHOSPHATE; NICOTINIC ACID; PHOSPHOROUS ACID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; OPEN STUDY; PRURITUS; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENTS; CALCIUM; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NIACIN; PHOSPHORUS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 33644515368     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-0001-x     Document Type: Article

References (19)

1. E Slatopolsky AM Robson JF Rosen 1968 Control of phosphate excretion in uremic man J Clin Invest 47 1865-1874 1:CAS:528:DyaF1cXkslGisLY%3D 5666116
2. Martin KJ, Gonzalez EA, Slatopolsky E. Brenner and Rector's The Kidney, Vol. 2, 7th edn. Saunders, 2004; 2255-2293.
3. Lorenzo V, Martin-Malo A, Perez-Garcia R et al. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: A cross-sectional multicentre study. Nephrol Dial Transplant. 2005 Nov 1; [Epub ahead of print].
4. RM Lindsay F Alhejaili G Nesrallah 2003 Calcium and phosphate balance with quotidian hemodialysis Am J Kidney Dis 42 1 Suppl 24-29 12830440
5. AC Alfrey GR Legendre WD Kaehny 1976 The dialyis encephalopathy syndrome. Possible aluminium intoxication N Engl J Med 294 184-188 1:STN:280:CSmD2srlvFQ%3D 1244532
6. E Slatopolsky C Weerts S Lopez-Hilker 1986 Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis N Eng J Med 315 157-161 1:STN:280:BimB2MjjtVE%3D
7. GA Block TE Hulbert-Shearon NW Levin 1998 Association of serum phosphorus and calciumxphosphate product with mortality risk in hemodialysis patients Am J Kidney Dis 31 601-617
8. F Meric P Yap MJ Bia 1990 Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy Am J Kid Dis 5 459-464
9. Y Slinin RN Foley AJ Collins 2005 Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study J Am Soc Nephrol 16 6 1788-1793 10.1681/ ASN.2004040275 1:CAS:528:DC%2BD2MXls1ehsr0%3D 15814832
10. GM Chertow SK Burke JM Lazarus 1997 Poly (allylamine hydrochloride)RenaGel: A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure Am J Kidney Dis 29 66-71 1:CAS:528:DyaK2sXnsVaksQ%3D%3D 9002531
11. E Slatopolsky H Liapis J Finch 2005 Progressive accumulation of lanthanum in the liver of normal and uremic rats Kidney Int 68 6 2809-2813 10.1111/j.1523-1755.2005.00753.x 1:CAS:528:DC%2BD28XhslWjtA%3D%3D 16316357
12. H Debiec R Lorenc 1988 Identification of Na, Pi binding protein in kidney and intestinal BB membranes Biochem J 255 1 185-191 1:CAS:528:DyaL1cXmtVOjsrk%3D 3196312
13. NA Breslau 1996 Calcium,magnesium and phosphorus: Intestinal absorption MJ Favus Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism Lippincott Raven Philadelphia 57-63
14. C Amiel 1996 Hypo-hyperphosphatemia A Davison S Cameron JP Grunfeld C Ponticelli E Ritz C Winearls Oxford TextBook of Clinical Nephrology Oxford University Press Oxford 249-269
15. N Eto Y Miyata H Ohno T Yamashita 2005 Nicotinamide prevents the development of hyperphophatemia by suppressing intestinal sodium dependent phosphate transporter in rats with adenine induced renal failure Nephrol Dial Transplant 20 1378-1384 1:CAS:528:DC%2BD2MXpt1Cjs7w%3D 15870221
16. Y Takahashi A Tanaka T Nakamura 2004 Nicotinamide suppresses hyperphosphatemia in hemodialysis patients Kidney Int 65 1099-1104 10.1111/j.1523-1755.2004.00482.x 1:CAS:528:DC%2BD2cXitleksbY%3D 14871431
17. K Shimoda T Akiba T Matsushima 1998 Niceritrol reduces serum phosphate in chronic hemodialysis patients Nippon Jinzo Gakkai Shi 40 1 1-7 1:STN:280:DyaK1c7nsVGlsA%3D%3D 9513376
18. N Kuboyama Y Watanabe M Yamaguchi 1999 Effects of niceritrol on fecal and urinary phosphate excretion in normal rats Nephrol Dial Transplant 14 3 610-614 1:CAS:528:DyaK1MXitFalsbs%3D 10193807
19. K Katai H Tanaka S Tatsumi 1999 Nicotinamide inhibits sodium dependent phosphate cotransport activity in rat small intestine Nephrol Dial Transplant 14 5 1195-1201 1:CAS:528:DyaK1MXjsFaqsrs%3D 10344361